RECRUITING

Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinicaI trial is being done to determine if acupressure is helpful to reduce anxiety related to chemotherapy, compared with "sham" (or placebo) acupressure in patients with cancer. Anxiety, experienced by many patients with cancer, can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicine ways to manage symptoms. Acupressure is the application of non-invasive finger pressure along energy points throughout the body in order to relieve pain and induce a feeling of well-being. Previous research has shown that acupressure can help both adults and children with their anxiety in certain situations, such as after surgery. Patients can be taught how to do the acupressure on themselves, making this an intervention that can be done anywhere. Acupressure is well tolerated with minimal reports of adverse reactions. Undergoing acupressure may be effective in reducing anxiety in cancer patients receiving chemotherapy.

Official Title

Acupressure for Anxiety: a Randomized Controlled Trial of an Acupressure Intervention for Patients Receiving Cancer-Directed Therapy

Quick Facts

Study Start:2024-12-11
Study Completion:2025-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06723041

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * NURSE-LED INTERVENTION: Age \>= 18 years and be diagnosed with cancer
  2. * NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy
  3. * NURSE-LED INTERVENTION: Ability to provide oral consent
  4. * NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
  5. * NURSE-LED INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
  6. * NURSE-LED INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
  7. * SELF-ADMINISTRATION INTERVENTION: Age \>= 18 years and be diagnosed with cancer
  8. * SELF-ADMINISTRATION INTERVENTION: Undergoing systemic, antineoplastic therapy
  9. * SELF-ADMINISTRATION INTERVENTION: Ability to provide oral consent
  10. * SELF-ADMINISTRATION INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
  11. * SELF-ADMINISTRATION INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
  12. * SELF-ADMINISTRATION INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
  13. * SELF-ADMINISTRATION INTERVENTION: Reports 2+/day anxiety episodes at home
  14. * SELF-ADMINISTRATION INTERVENTION: Interested in learning self-administered acupressure
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Clinical Trials Referral Office
CONTACT
855-776-0015
mayocliniccancerstudies@mayo.edu
Jennifer Manggaard
CONTACT
507-255-7768
Manggaard.Jennifer@mayo.edu

Principal Investigator

Elizabeth Cathcart-Rake, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Elizabeth Cathcart-Rake, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic in Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-11
Study Completion Date2025-05-30

Study Record Updates

Study Start Date2024-12-11
Study Completion Date2025-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm